Otsuka Sues Aurobindo To Halt Generic Abilify
Otsuka Pharmaceutical Co. Ltd. filed suit Friday against Aurobindo Pharma Ltd. and its subsidiaries in New Jersey federal court, alleging Aurobindo's bid to market a generic version of its bipolar disorder,...To view the full article, register now.
Already a subscriber? Click here to view full article